ID
24861
Descrição
Study ID: 100571 (M138) Clinical Study ID: 100571 Study Title: Double-blind randomized study to evaluate the immunogenicity and reactogenicity of two different lots of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine containing 1440 EL.U of antigen per mL and injected according to a 0, 12 month schedule in healthy adult volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00291876 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 4 Study Recruitment Status: Completed Generic Name: Hepatitis A Vaccine, Inactivated Trade Name: Havrix Study Indication: Hepatitis A https://clinicaltrials.gov/ct2/show/NCT00291876
Link
https://clinicaltrials.gov/ct2/show/NCT00291876
Palavras-chave
Versões (1)
- 20/08/2017 20/08/2017 -
Titular dos direitos
GlaxoSmithKline
Transferido a
20 de agosto de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
GSK Hepatitis A Vaccine VISIT 23 ADDITIONAL VACCINATION VACCINE ADMINISTRATION NCT00291876
GSK Hepatitis A Vaccine VISIT 23 ADDITIONAL VACCINATION VACCINE ADMINISTRATION NCT00291876
Similar models
GSK Hepatitis A Vaccine VISIT 23 ADDITIONAL VACCINATION VACCINE ADMINISTRATION NCT00291876
C2348563 (UMLS CUI [1,2])
C0013153 (UMLS CUI [1,2])
C0042210 (UMLS CUI [1,3])